Tag Archives: Roche

Influenza A(H1N1): Antivirales y antibióticos se venden sin control.

México enfrenta la segunda oleada de la epidemia de Influenza A H1N1 que seguramente atacará con mayor fuerza en este invierno. Ante este escenario, México no cuenta con ningún mecanismo de control que impida la venta de antibióticos y antivirales sin receta. … Continue reading

Posted in Ciencia, Opinión, Salud | Tagged , , , , , , , , , , , , , , , , , , , | 3 Comments

AH1N1 Flu, Kimberly-Clark and the “Condom Effect”

By Xavier Tello The current AH1N1 Flu pandemic has unexpectedly brought benefits to some companies; and we are not talking about Tamiflu’s manufacturer Roche or Influenza Vaccine experts such as Glaxo or sanofi-aventis. Last July 23rd, Kimberly-Clark Corporation announced its … Continue reading

Posted in Alta Dirección, Mercadotecnia, Opinión, Ventas | Tagged , , , , , , , , , , , , , , , , , , | 1 Comment

2009 Pharma Mergers. A comprehensive analysis facing the future.

The last two months have been full of surprises in the Pharmaceutical arena. January was not even ending, when Pfizer was announcing its intentions of taking over Wyeth. Just some days after a month later and after a more-than-nervous weekend, … Continue reading

Posted in Alta Dirección, Mercadotecnia, Opinión, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 3 Comments

Improving Patient Compliance, an impressive challenge and a costly task.

  By Xavier Tello One of the most important [not so] hidden costs of therapeutics and health care, is patients’ lack of adherence to treatment. According to several authors, including a review of the Cochrane Collaboration, the “desertion” index could … Continue reading

Posted in Mercadotecnia, Opinión, Planeac. Estratégica, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 5 Comments

Regulación y Ética en el trabajo de los Representantes Médicos

El pasado 19 de enero, se publicó en REFORMA un artículo de Sara Cantera intitulado: “Regulan Visitas de los Laboratorios”. En esta pieza, en la que tuvimos el gusto de colaborar, se hace referencia a dos nuevas disposiciones para la … Continue reading

Posted in Alta Dirección, Mercadotecnia, Planeac. Estratégica, Salud, Ventas | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment